Jacqueline Cloos
21PUBLICATIONS
62CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (21)
Sort by Publication Date:
|Mar 19, 2026
Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy.Lukas H Haaksma, Tom Reuvekamp, Kasper J Croese
|Dec 10, 2025
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia.Lukas H Haaksma, Raffaele Palmieri, Tom Reuvekamp
|Sep 03, 2025
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial.Tim R Mocking, Lukas H Haaksma, Tom Reuvekamp
|Aug 20, 2025
Flow cytometric and molecular MRD in AML: current methods, clinical applications and challenges.Lukas H Haaksma, Jacqueline Cloos, David C de Leeuw
|May 22, 2025
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia.Tim R Mocking, Arjan A van de Loosdrecht, Jacqueline Cloos
Pageof 4
Frequent Collaborators
11 joint publications
Costa Bachas
6 joint publications
David C de Leeuw
6 joint publications
Tom Reuvekamp
5 joint publications
Lok Lam Ngai
5 joint publications
Arjan A van de Loosdrecht
5 joint publications
Jesse M Tettero
4 joint publications
Tim R Mocking
4 joint publications
Lukas H Haaksma
4 joint publications
Thomas Pabst
3 joint publications
Bob Löwenberg